News
Our News
News Center
How API Drugs Be Classified?
The pharmaceutical industry is constantly evolving, with new drugs being…
Apalutamide: A Second-Generation NSAA for Non-Metastatic Castration-Resistant Prostate Cancer
Apalutamide, a second-generation nonsteroidal antiandrogen (NSAA), has emerged as a…
Oclacitinib for Treating Pruritus and Beyond
In recent years, the landscape of managing atopic dermatitis and…
Ruxolitinib: From API to Breakthrough Vitiligo Treatment
Ruxolitinib, a potent Janus kinase (JAK) inhibitor, has carved its…
CPHI Barcelona 2023
From October 24th to 26th, 2023, Qingmu was at the…
VIV Asia 2023 in Thailand
From March 8th to 10th, 2023, we were exhibiting at…
CPHI Japan 2023
From April 19th to 21st, 2023, we were exhibiting at…
CPHI Shanghai 2023
From June 19 to 21, 2023, Qingmu was at the…
The Uses of Rotigotine in Parkinson’s Disease Treatment
Parkinson’s disease, a neurodegenerative disorder affecting millions globally, casts a…
Sugammadex Sodium: Seven Key Points for Optimal Clinical Application
Sugammadex sodium, a revolutionary neuromuscular blocker (NMB) reversal agent, has…
What are the Benefits of Apalutamide?
In the ever-evolving landscape of cancer therapeutics, Apalutamide has emerged…
Potential of Lenvatinib Mesylate in Liver Cancer Treatment
Liver cancer continues to pose a formidable challenge to global…
